Abstract-Synthesis of some novel aminocyclopentitol analogues has been achieved through a functionally embellished cyclopentanoid derivative of well-defined stereochemical disposition, obtained via a Grob-type fragmentation sequence executed within the norbornyl framework. The glycosidase inhibition studies of the new aminocyclopentitols indicate them to be weak inhibitors.
Abstract-Synthesis of some novel aminocyclopentitol analogues has been achieved through a functionally embellished cyclopentanoid derivative of well-defined stereochemical disposition, obtained via a Grob-type fragmentation sequence executed within the norbornyl framework. The glycosidase inhibition studies of the new aminocyclopentitols indicate them to be weak inhibitors.
Recent years have witnessed a great deal of interest in the synthesis of polyhydroxylated aminocyclopentanes (aminocyclopentitols), which either exist as such in nature or constitute important sub-structures among several complex natural products, and display a wide range of biological activity profiles. 1 Among the well known examples of this class of molecules of contemporary interest are glycosidase inhibitors mannostatin A 1, trehazolin 2 and their synthetic analogues such as Merrel Dow's cyclopentylamine 3 and recently disclosed aminocyclopentitols 4a and 4b, and carbocyclic nucleosides such as neplanocin A 5, aristeromycin 6 and their analogues. [1] [2] [3] In the context of glycosidase inhibition, these compounds can be considered as structural analogues of carbohydrates containing a basic nitrogen function at the anomeric center in the protonated form. Generally, their mode of action is presumed to proceed via mimicking of the glycopyranosyl cation in the transition state of the glycosidase catalyzed reaction.
4 Besides 1-6, several aminocyclopentitol based glycosidase inhibitors, having gluco-, manno-, galactoand fuco-stereochemical patterns have been synthesized and evaluated against their corresponding glycosidases in the recent past. [1] [2] [3] However, glycosidase inhibition by aminocyclopentitols as a function of their structural and stereochemical features still remains to be fully understood 2b-f and, therefore, the synthesis of newer analogues could provide not only a better understanding of glycosidase functioning but also lead to more active inhibitors, which can be used for the treatment of carbohydrate metabolism related disorders. closed a stereoselective synthesis of the densely functionalized cyclopentanoid framework 9 through further elaboration of the cyclopentene ester 8, obtained in a Grob-type fragmentation sequence orchestrated within the norbornyl framework 7, Scheme 1. 5c Herein, we report the transformation of cyclopentanoid framework 9 to new aminocyclopentitols having the altrose configuration and to an analogue of the carbocyclic nucleoside neplanocin A, in which the amino and hydroxy functionalities are transposed, and evaluate their glycosidase inhibition activity.
The free hydroxy group in 9 was first activated as a leaving group in the form of the mesylate functionality and then the iodide was subjected to reductive dehalogenation with NaBH 3 CN to furnish the methyl compound 10 6 (Scheme 2). In order to set up the requisite amine functionality, the mesylate group in 10 was displaced using NaN 3 as a nucleophile to afford 11. 6 Catalytic hydrogenation of the azide group in 11 provided an access to the free amine, which was purified and characterized as its acetamide derivative 12.
6 Acid catalyzed deprotection of the amide as well as the acetonide group in 12 was effected smoothly to furnish the desired amine, a stereoisomer of the potent inhibitor 4b, 2f as its hydrochloride salt 13 6 (Scheme 2). In a related sequence, the mesylate 14 derived from 9 on peracid mediated oxidation of the iodomethyl functionality was directly transformed to the hydroxy compound 15. 6 Alternately, 15 could also be accessed from 14 via dehydroiodination to the exocyclic olefin and hydroboration-oxidation. However, the yield and stereoselectivity in this sequence was rather modest. Further, the mesylate group in 15 was smoothly displaced by the azide anion to yield 16, which was further transformed to 17, 6 closely related to the powerful inhibitor 4a, 2e in a two-step sequence involving azide group reduction and acid catalyzed deprotection of the acetonide moiety see (Scheme 2).
Syntheses of novel amino cyclopentitols with an amino group in the side-chain and the carbocyclic nucleoside analogue of neplanocin A 5 in which the purine and hydroxy group positions on the cyclopentitol moiety are swapped was attempted next as outlined in Scheme 3. Sodium azide mediated displacement of the iodomethyl group and concomitant elimination of the mesylate group in 14 led directly to 18 with the requisite disposition of the double bond (cf. 5). Reduction of the azide group in 18 under carefully crafted conditions generated the aminomethyl derivative 19, 6 which upon deprotection of the acetonide protective group yielded the novel cyclopentitol with a primary amino group 20, as its hydrochloride salt. In a related sequence, sodium acetate mediated displacement of the iodo functionality and concomitant elimination of the mesylate group in 14 furnished 21, which upon alkaline hydrolysis provided access to 22. 6 To transform 22 into the carbocyclic nucleoside analogue, the adenine moiety was attached to it under Mitsunobu conditions in a regiose- lective manner to deliver 23. 6 Acid catalyzed deprotection of the acetonide moiety in 23 led directly to the formation of 24. 6 The 1 H and 13 C NMR spectra of both 23 and 24 clearly indicated the N9 substituted structures rather than the N7 substituted structures 7 . It is to be noted that structural analogues of carbocyclic nucleosides have evoked a great deal of attention 1b as anti-viral and anti-HIV agents and to our knowledge 24 represents a new variation.
Glycosidase inhibitory activity of aminocyclopentitol derivatives 13 and 17 having the altrose configuration, and of the carbocyclic nucleoside analogue 24 and the related aminocyclopentene derivative 20 was evaluated against a-glucosidase (yeast), b-glucosidase (sweet almond), a-galactosidase (green coffee beans) and bgalactosidase (E. coli ) using their corresponding orthoor para-nitrophenyl-glycopyranosides as substrates at optimum pH and temperature of each enzyme. While the methyl derivative 13 was found to be a weak anomer selective and competitive inhibitor of a-glucosidase (K i =503 mM), the hydroxymethyl derivative 17 turned out to be an even weaker inhibitor with only 13% inhibition at 1 mM concentration. Methyl substituted aminocyclopentitol 13 showed a non-selective inhibition against a-and b-galctosidases with 30 and 40% inhibition, respectively, at 1 mM concentration whereas there was no observable inhibition by 17 in the case of other glycosidases. This marked decrease in the inhibitory activity of 13 and 17, as compared with the closely related diastereomeric aminocyclopentitols reported recently (cf. 4a,b),
2b-e could be attributed to the mismatch of configuration with the transition-state of corresponding enzymes. The carbocyclic nucleoside analogue 24 and the related aminocyclopentene 20 did not show any glycosidase inhibition against the enzymes studied by us, underscoring the need for a wider screen.
In conclusion, we have demonstrated the versatility of readily available cyclopentanoid derivative 9 5c in stereospecific synthesis of two new aminocyclopentitols 13 and 17 with previously unknown stereochemical dispositions. A novel carbocyclic nucleoside analogue 24 of neplanocin A is also reported. While 13 was found to be a weak anomer selective inhibitor of a-glucosidase, the other cyclopentitols 17, 20, 24 were ineffective as glycosidase inhibitors.
